Doctor Minako Kagimoto
Yokohama city university hospital, Yokohama (Japan)
Plasma lysoGb3 useful as biomarker in screening for Fabry disease in patients with mild left ventricular hypertrophy
Event: ESC Congress 2018
Topic: Infiltrative Myocardial Disease
Session: Cardiomyopathy in Fabry disease
ESC 365 is supported by
